Diabetes is a chronic metabolic disease with over 300 million people suffering worldwide. Insulin insufficiency is found in type 1 diabetes and, combined with insulin resistance, in type 2 diabetes. Although the cause of insulin insufficiency is generally considered to be a result of β-cell damage by autoimmunity, a high percentage of diabetic patients with insulin insufficiency show negative of those autoantibodies. Up to 50% adult patients with cystic fibrosis (CF), a disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), develop CF-related diabetes (CFRD) with most patients exhibiting insulin insufficiency. Our recent studies have explored the possible involvement of CFTR in regulating the electrophysiological activities of pancreatic β cells required for insulin secretion. The results show that the glucose-elicited whole-cell currents, membrane depolarization, electrical bursts or action potentials, Ca 2+ oscillations and insulin secretion are abolished or reduced by inhibitors or knockdown of CFTR in primary mouse β-cells or RINm5F β-cell line, or significantly attenuated in CFTR mutant (ΔF508) mice compared with wild-type mice. VX-809, a newly discovered corrector of ΔF508 mutation, successfully rescues the defects in ΔF508 β-cells. Our results reveal a role of CFTR in glucose-induced electrical activities and insulin secretion in β-cells, and shed light on the pathogenesis of CFRD and possibly other idiopathic diabetes.
S1.2 CFTR AND AIRWAY HOST DEFENSE IN THE CF PIG MODELMahmoud H. Abou Alaiwa, M.D.
Internal Medicine, University of Iowa, Iowa City, IA, USAAirways evolved with multiple host defense mechanisms to protect against invading organisms (1-4). At the interface with the environment is a thin layer of airway surface liquid (ASL) equipped with antimicrobial factors that rapidly kill bacteria and mucus that rapidly clears trapped pathogens (5). Cystic fibrosis (CF) lung disease is characterized by recurrent bacterial airway infections, accumulation of mucus, inflammation, and progressive decline in lung function. Despite advances in antibiotic formulations and mucus mobilization maneuvers, CF lung disease continues as the leading cause of morbidity and mortality in people with CF (6). Development of the CF pig and other animal models has added understanding of the pathogenesis of early CF airway disease (7, 8). At birth, CF pig lungs show no inflammation or infection but demonstrate a bacterial host defense defect. Over time, CF pigs spontaneously develop the hallmark features of CF airway disease with infection, inflammation, airway obstruction and airway remodeling (9). We examined CF pigs within hours of birth and discovered two host defense defects. First, CF ASL is abnormally acidic, which inhibits the activity of antimicrobial peptides and proteins (10). This low ASL pH not only affects the antimicrobial activity of individual antimicrobial factors, but also their synergistic interactions (11). Second, impaired anion secretion by CF submucosal gland...